Support is requested for a Keystone Symposia meeting entitled Immune Evolution in Cancer, organized by Suzanne Ostrand-Rosenberg, Olivera J. Finn and Lisa M. Coussens. The meeting will be held in Whistler, British Columbia, Canada from March 9-14, 2014. Neoplastic progression is initiated by accumulations of somatic mutations in proliferating cells that cause "healthy" cells to sustain survival programs and resist embedded tissue-based programs designed to restrain their unchecked proliferation. Concurrent with neoplastic progression, the immune system sculpts the neoplastic cell repertoire by eliminating immunogenic cells while allowing outgrowth of less immunogenic variants, a process known as immunoediting. As neoplasms undergo early progression, they often resemble a chronic "wound" wherein activated tissue remodeling, and immune and angiogenic programs facilitate the survival of potentially malignant cells. Cells of the adaptive and innate immune systems are particularly important during wound healing, however during cancer development, many immune cells are co-opted and effectively "reprogrammed" towards a tumor- promoting phenotype. As a result, malignant cells condition their environment to facilitate their progression by co-opting multiple immune effector cell populations. Presentations at this conference will focus on how the tumor microenvironment perturbs lymphoid and myeloid cells, the mechanisms used by immune cells to promote tumor growth, and the strategies being developed to counteract tumor-induced immune suppression to generate anti-tumor immunity. Many of the tumor-promoting effects of the immune system are regulated by leukocyte infiltration, e.g., chronic inflammation, thus this conference, in conjunction with the companion conference on Inflammation, Infection and Cancer, will provide an in-depth examination of the current understanding of tumor progression, and will facilitate interactions between tumor immunologists and cancer biologists.

Public Health Relevance

The Keystone Symposia meeting on Immune Evolution in Cancer will bring together investigators studying the progressive changes that occur in immune cells during tumor development and growth. The overall goals of this meeting - and the companion meeting on Inflammation, Infection and Cancer - are to advance our understanding of the mechanisms by which cancer cells obstruct anti-tumor immunity, to provide new insights for the development of immune-based anti-cancer therapies, and to promote the development of junior investigators in the field of cancer immunology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Conference (R13)
Project #
1R13CA182664-01
Application #
8621191
Study Section
Special Emphasis Panel (ZCA1-PCRB-G (O1))
Program Officer
Williams, Michelle C
Project Start
2014-03-01
Project End
2015-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
1
Fiscal Year
2014
Total Cost
$5,000
Indirect Cost
Name
Keystone Symposia
Department
Type
DUNS #
079780750
City
Silverthorne
State
CO
Country
United States
Zip Code
80498